Harris Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $631K | Sell |
|
|||||
|
2023
Q1 | $1.55M | Sell |
|
|||||
|
2022
Q4 | $64.7M | Sell |
|
|||||
|
2022
Q3 | $130M | Sell |
|
|||||
|
2022
Q2 | $344M | Sell |
|
|||||
|
2022
Q1 | $763M | Sell |
|
|||||
|
2021
Q4 | $834M | Sell |
|
|||||
|
2021
Q3 | $803M | Sell |
|
|||||
|
2021
Q2 | $807M | Buy |
|
|||||
|
2021
Q1 | $489M | Buy |
|
|||||
|
2020
Q4 | $255M | Sell |
|
|||||
|
2020
Q3 | $373M | Sell |
|
|||||
|
2020
Q2 | $765M | Sell |
|
|||||
|
2020
Q1 | $1.13B | Sell |
|
|||||
|
2019
Q4 | $1.64B | Buy |
|
|||||
|
2019
Q3 | $1.15B | Buy |
|
|||||
|
2019
Q2 | $1.23B | Buy |
|
|||||
|
2019
Q1 | $1.1B | Sell |
|
|||||
|
2018
Q4 | $1.12B | Sell |
|
|||||
|
2018
Q3 | $1.28B | Buy |
|
|||||
|
2018
Q2 | $1.09B | Buy |
|
|||||
|
2018
Q1 | $585M | Buy |
|